PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008180
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008180
Europe Iv Hydration Therapy Market is estimated to be valued at USD 616.7 Mn in 2026 and is expected to reach USD 1,330.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 616.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.70% | 2033 Value Projection: | USD 1,330.4 Mn |
IV therapy, also known as IV hydration therapy, is a treatment that boosts the body's immunity by replenishing it with important vitamins, antioxidants, and minerals. The technique, which is similar to drip hydration used in hospitals, helps ease symptoms of dehydration and other disorders by delivering nutrients directly into the bloodstream via drips. It is also believed that nutritional IV therapy can provide a variety of health benefits, including eliminating toxins from the body, increasing energy levels, and promoting better cardiovascular health, among others.
The increasing adoption of growth strategies by the key players in the market such as geographic expansion in order to enhance its market position at global level is expected to drive the market growth over the forecast period. For instance, in September 2021, VITANOVAS, a mobile IV infusion company, announced that the company is planning to develop into franchised clinics in Brussels, Belgium and Cancun, Mexico. The aim behind this expansion of VITANOVAS for IV therapy is to expand the business at global level.
Moreover, rising prevalence of obesity is expected to drive the market growth over the forecast period as IV hydration supports weight loss with fluids that body needs to thrive. For instance, according to the data published by Eurostat, the statistical office of the European Union, responsible for publishing high-quality Europe-wide statistics, in July 2021, more than half (53%) of adults in Europe were overweight (36% pre-obese and 17% obese) in the year 2019
Key features of the study